Shopping Cart
- Remove All
- Your shopping cart is currently empty
JSH-009 is a novel and highly selective CDK9 inhibitor crucial for regulating transcription elongation. It demonstrates significant in vitro and in vivo efficacy against acute myeloid leukemia (AML).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | JSH-009 is a novel and highly selective CDK9 inhibitor crucial for regulating transcription elongation. It demonstrates significant in vitro and in vivo efficacy against acute myeloid leukemia (AML). |
Molecular Weight | 519.10 |
Formula | C25H35ClN6O2S |
Cas No. | 2247481-08-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.